Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy

Glioblastoma is the most common and lethal brain cancer globally. Clinically, this cancer has heterogenous molecular and clinical characteristics. Studies have shown that UBE2S is highly expressed in many cancers. But its expression profile in glioma, and the correlation with clinical outcomes is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Li, Cheng, Xingbo, Binder, Zev, Han, Zhibin, Yin, Yibo, O’Rourke, Donald M., Wang, Sida, Feng, Yumeng, Weng, Changjiang, Wu, Anhua, Lin, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190380/
https://www.ncbi.nlm.nih.gov/pubmed/34123793
http://dx.doi.org/10.3389/fonc.2021.640910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190380/
https://www.ncbi.nlm.nih.gov/pubmed/34123793
http://dx.doi.org/10.3389/fonc.2021.640910

Ejemplares similares